The health service could save up to €1 billion in its medicines budget over the next five years, according to the group representing the sector. Photograph: Getty

The health service could save up to €1 billion in its medicines budget over the next five years through increased use of generic and biosimilar produc(...)

MFI says Irish patients did not experience shortages of drugs and medicines as a result of the  pandemic. Photograph: Getty Images

The impact of Covid-19 and Brexit could pose a risk of a shortage of medicines in the months ahead, representatives of key parts of the pharmaceutical(...)

A sanitisation operation in the streets of the Quartieri Spagnoli of Naples, to stem the danger of contagion and spread of Covid-19

Irish medicine supplies remain strong despite Covid-19, the Irish pharmaceutical trade association has said as the European Union announced a new €50 (...)

Medicines for Ireland says the generic substitution and reference pricing regime has delivered savings of €1.6 billion to the State since 2013. Photograph: Russell Boyce/Reuters

Ireland’s cash-strapped health service is missing out on almost €140 million in savings on its medicines bill by failing to encourage competition by (...)

The Irish Pharmaceutical Healthcare Association says the Government accepts that its medicines bill has been “relatively stable” at about €1.7 billion for the past five years. Photograph: Cyril Byrne

Prices across 750 medicines have fallen in a move that will save the Government €15 million on its drugs budget, according to the industry body Ipha. (...)

Pharmaceuticals: Brexit could create “significant problems” as drug companies are forced to comply with two separate regulatory regimes. Photograph: Akos Stiller/Bloomberg

Brexit could lead to shortages of medicines in Ireland and higher costs for an already overstretched HSE drug budget, an industry group has warned. M(...)

UK Brexit secretary David Davis. Photograph: Jonathan Brady/PA Wire

Patients are at risk of not having access to potentially life saving drugs if Britain and the European Union fail to agree ongoing co-operation in the(...)

Sources in the pharmaceutical sector say a further 14 novel drugs were coming through the approvals system but there appeared to be no scope in the medicines budget to pay for them

Ireland needs a national strategy to cope with its rapidly rising medicines bill, especially if it hopes to afford a range of expensive new therapies (...)